TON - May 2018, Vol 11, No 2
The Oncology Nurse-APN/PA spoke with Salimah H. Meghani, PhD, MBE, RN, FAAN, a faculty member at the University of Pennsylvania School of Nursing, Philadelphia, about her various roles and thoughts on what is exciting in the field of palliative care.
The Academy of Oncology Nurse & Patient Navigators had a strong presence at the first of the Biden Cancer Initiative’s “Conversation with Dr Biden,” on March 10, 2018. These conversations provide members of the patient support network with the opportunity to share their perspectives on the cancer journey.
Preclinical studies suggested potential therapeutic synergy with the combination of atezolizumab and cobimetinib. To evaluate the combination, investigators conducted a 2-stage, phase 1b dose-escalation/cohort-expansion trial involving patients with several types of advanced solid tumors, including chemotherapy-refractory locally advanced or mCRC.
This article will discuss some of the characteristics that contribute to poor prognosis in infants with ALL, the results of clinical trials evaluating newer therapies to treat the disease, and what the future holds in terms of novel strategies.
“Adjuvant chemotherapy improves disease-free survival and metastasis-free survival. It is feasible in a group of patients with the majority over age 60 years," stated lead investigator Alison Jane Birtle, MD, MBBS, MRCP, FRCR, Consultant Clinical Oncologist, Rosemere Cancer Centre, Royal Preston Hospital, England.
Results 1 - 10 of 13